VNRX
VolitionRX Ltd
Halal Rating :
Last Price
$0.62
Last updated:
Market Cap
-
7D Change
0.06%
1 Year Change
-37.79%
Company Overview
Industries
Exchange
Next Earnings Date
VolitionRx Limited is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases, particularly in the fields of cancer and other diseases. The company's tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $474522.0 | $6.43m | - | $89456.0 | 0.00% | 1.39% |
| June 30, 2024 | $395797.0 | $7.47m | - | $81182.0 | 0.00% | 1.09% |
| March 31, 2024 | $131759.0 | $8.56m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate VolitionRX Ltd's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.